Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Johannesson, Magnus
and
Jönsson, Bengt
1991.
Economic evaluation in health care: Is there a role for cost-benefit analysis?.
Health Policy,
Vol. 17,
Issue. 1,
p.
1.
Johannesson, Magnus
1992.
Economic Evaluation of Hypertension Treatment.
International Journal of Technology Assessment in Health Care,
Vol. 8,
Issue. 3,
p.
506.
Johannesson, Magnus
1992.
On the Discounting of Gained life-Years in Cost-Effectiveness Analysis.
International Journal of Technology Assessment in Health Care,
Vol. 8,
Issue. 02,
p.
359.
Nord, Erik
1993.
Toward Quality Assurance in QALY Calculations.
International Journal of Technology Assessment in Health Care,
Vol. 9,
Issue. 1,
p.
37.
Johannesson, Magnus
Pliskin, Joseph S.
and
Weinstein, Milton C.
1994.
A Note on QALYs, Time Tradeoff, and Discounting.
Medical Decision Making,
Vol. 14,
Issue. 2,
p.
188.
Jefferson, Tom
and
Demicheli, Vittorio
1994.
Is vaccination against hepatitis b efficient? A review of world literature.
Health Economics,
Vol. 3,
Issue. 1,
p.
25.
Schwab Christe, Nathalie G.
and
Soguel, Nils C.
1996.
The pain of road-accident victims and the bereavement of their relatives: A contingent-valuation experiment.
Journal of Risk and Uncertainty,
Vol. 13,
Issue. 3,
p.
277.
Johannesson, Magnus
1996.
Theory and Methods of Economic Evaluation of Health Care.
Vol. 4,
Issue. ,
p.
173.
Garuz, Roberto
Torrea, JoséLuis
Arnal, JoséMaría
Forcen, Tarsicio
Trinxet, Cristina
Anton, Francisco
and
Antoñanzas, Fernando
1997.
Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis.
Vaccine,
Vol. 15,
Issue. 15,
p.
1652.
Zarnke, Kelly B
Levine, Mitchell A.H
and
O'Brien, Bernie J
1997.
Cost-Benefit Analyses in the Health-Care Literature: Don't Judge a Study by Its Label.
Journal of Clinical Epidemiology,
Vol. 50,
Issue. 7,
p.
813.
Søgaard, Jes
and
Gyrd-Hansen, Dorte
1998.
Health, the Medical Profession, and Regulation.
Vol. 6,
Issue. ,
p.
51.
Rubio Cebrián, S.
Solano Bernad, V.M.
Hernández Navarrete, Ma.J.
Peral Casado, A.
Sierra Moros, Ma.J.
Castán Cameo, S.
and
Arribas Llorente, J.L.
1998.
Costes de las inoculaciones accidentales en personal sanitario de un hospital.
Gaceta Sanitaria,
Vol. 12,
Issue. 1,
p.
29.
Tasset, Anne
Nguyen, Van Hung
Wood, Susan
and
Amazian, Kamelia
1999.
Discounting: technical issues in economic evaluations of vaccination.
Vaccine,
Vol. 17,
Issue. ,
p.
S75.
Levaux, Hugh P.
Schonfeld, Warren H.
Pellissier, James M.
Cassidy, William M.
Sheriff, Sara K.
and
Fitzsimon, Catherine
2001.
Economic Evaluation of a 2-Dose Hepatitis B Vaccination Regimen for Adolescents.
Pediatrics,
Vol. 108,
Issue. 2,
p.
317.
García‐Altés, Anna
2001.
Twenty years of health care economic analysis in Spain: are we doing well?.
Health Economics,
Vol. 10,
Issue. 8,
p.
715.
Sacristán, J.A.
Oliva, J.
Del Llano, J.
Prieto, L.
and
Pinto, J.L.
2002.
¿Qué es una tecnología sanitaria eficiente en España?.
Gaceta Sanitaria,
Vol. 16,
Issue. 4,
p.
334.
Bos, Jasper M
Beutels, Philippe
Annemans, Lieven
and
Postma, Maarten J
2004.
Valuing Prevention Through Economic Evaluation.
PharmacoEconomics,
Vol. 22,
Issue. 18,
p.
1171.
Doctor, Jason N.
Bleichrodt, Han
and
Lin, H. Jill
2010.
Health Utility Bias: A Systematic Review and Meta-Analytic Evaluation.
Medical Decision Making,
Vol. 30,
Issue. 1,
p.
58.
García-Altés, Anna
2013.
Systematic review of economic evaluation studies: Are vaccination programs efficient in Spain?.
Vaccine,
Vol. 31,
Issue. 13,
p.
1656.
Standaert, Baudouin
Sauboin, Christophe
DeAntonio, Rodrigo
Marijam, Alen
Gomez, Jorge
Varghese, Lijoy
and
Zhang, Sharon
2020.
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future.
Journal of Market Access & Health Policy,
Vol. 8,
Issue. 1,
p.
1719588.